FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

39609711000001108: Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jun 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1821681000001118 Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1821691000001116 Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Belantamab mafodotin 100mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has excipient Edetate disodium false Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Is a Blenrep true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Has specific active ingredient Belantamab mafodotin true Inferred relationship Existential restriction modifier
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial Has AMP True Blenrep 100mg powder for concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start